Prudential Financial2001 Annual Report  
Front CoverFinancial HighlightsIntroductionMessage from the ChairmanCorporate ProfileOfficers and DirectorsFinancial Section Forward-Looking StatementsShareholder Information
View Proxy Statement
Financial Section

Financial Section
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Consolidated Financial Statements
Notes to Consolidated Financial Statements
Note 1 Business
Note 2 Summary of Significant Accounting Policies
Note 3 Discontinued Operations
Note 4 Capital Markets Restructuring
Note 5 Acquisition of Kyoei Life Insurance Company, Ltd.
Note 6 Investments
Note 7 Deferred Policy Acquisition Costs
Note 8 Policyholders' Liabilities
Note 9 Closed Block
Note 10 Reinsurance
Note 11 Short-Term and Long-Term Debt
Note12 Equity Security Units
Note 13 Stockholders' Equity
Note 14 Earnings Per Share
Note 15 Stock Options
Note 16 Employee Benefit Plans
Note 17 Income Taxes
Note 18 Fair Value of Financial Instruments
Note 19 Derivative Instruments
Note 20 Segment Information
Note 21 Commitments and Guarantees, Contingencies and Litigation
Note 22 Quarterly Results of Operations (Unaudited)
Supplemental Combining Financial Information
Market for Common Equity and Related Stockholder Matters




Notes to Consolidated Financial Statements

The Company's Board of Directors adopted the Prudential Financial, Inc. Stock Option Plan (the "Plan"). Nonqualified Stock Options and Incentive Stock Options as well as Stock Appreciation Rights ("SARs") are eligible for grant under the plan. Participants can be employees and non-employees (i.e., statutory agents who perform services for the Company and participating subsidiaries). The Company made one type of grant, the Associates Grant, in 2001. The Associates Grant is a broad based award, which granted 240 options per full-time participant and 120 options per part-time participant. Each option has an exercise price no less than the fair market value of the Company's stock on the date the option is granted. The options have a maximum term of 10 years. Generally, one third of the option grant vests in each of the first three years; accordingly, options granted in 2001 generally will become eligible for exercise in years 2002 through 2004. A total of 12,322,009 shares have been authorized for grant under the Associates Grant. A total of 30,805,024 shares are available for the general grant of Options and SARs under the Plan. There were no options granted or outstanding relating to the general grant of Options and SARs at December 31, 2001.

The Company has elected to apply "Accounting Principles Board Opinion No. 25 Accounting for Stock Issued to Employees" and related interpretations in accounting for its employee stock options. If the Company had elected to account for its stock options under the fair value method of SFAS No. 123 "Accounting for Stock Based Compensation," the Company's net income and earnings per common share would have been reduced to the proforma amounts indicated below:

Employee Stock Option Grants

The compensation expense recognized for stock based employee compensation awards was zero for the period December 18, 2001 through December 31, 2001.

The fair value of each option is estimated on the date of grant using a Black-Scholes option-pricing model with the following weighted average assumptions used for grants in 2001:

The dividend yield reflects the assumption that the current dividend payout will continue with no anticipated increases.

A summary of the status of the Company's employee stock option grants at December 31, and changes during the year ended is presented below:

Employee options granted and their related grant date weighted average fair value is isolated in further detail in the schedule below:

There were no significant modifications to employee options outstanding for the year presented.

The following table summarizes information about the employee stock options outstanding at December 31, 2001:

Non-employee Stock Option Grants

The Company applies SFAS No. 123 "Accounting for Stock Based Compensation" in accordance with Emerging Issues Task Force Issue No. 96-18 "Accounting for Equity Instruments That Are Issued to Other Than Employees" and related interpretations in accounting for its non-employee stock options.

The compensation expense recognized for stock based non-employee compensation awards was $270 thousand for the period December 18, 2001 through December 31, 2001.

The fair value of each option is estimated on the balance sheet date for non-vested options and on the vesting date for vested options using a Black-Scholes option-pricing model with the following weighted average assumptions used for grants in 2001:

The dividend yield reflects the assumption that the current dividend payout will continue with no anticipated increases.

A summary of the status of the Company's non-employee stock option grants at December 31 and changes during the year ended is presented below:

There were no significant modifications to non-employee options outstanding for the year.

The following table summarizes information about the non-employee stock options outstanding at December 31, 2001:


Previous Home Next

 
OnlineProxy.com, LLC Web Site Design Patent Pending